Scholarlink

Introduction <p>Multimorbidity is a major challenge for healthcare systems. While multiple methods exist to measure it from electronic health records (EHRs), their relative performance for predicting hospital utilization is unclear.</p> Study Design and Methods <p>We conducted a retrospective cohort study using 15 years of EHR data (2007–2022) from a Portuguese hospital, including 925,508 patients and 9·7 M visits. Three phenotyping strategies were compared: a multi-source rule-based dictionary, Clinical Classification Software Refined (CCSR) mapping, and drug-based mapping. Five multimorbidity indices were evaluated: Charlson Comorbidity Index (ChCI), Elixhauser, Multimorbidity Weighted Index (MWI), RxRisk, and disease counts. Outcomes included emergency department (ED) visits, hospital admissions, unplanned admissions, and readmissions over 30–365 days, modeled with logistic regression (LR) and XGBoost.</p> Results <p>Best performance was achieved with XGBoost (AUROC 0.671–0.681 for ED visits, 0.663–0.668 for admissions, 0.773–0.781 for unplanned admissions, 0.798–0.848 for readmissions), with AUPRC patterns consistent with AUROC rankings. In LR models comparing indices, multimorbidity improved AUROC by 0.024–0.150 over demographics. MWI performed best for ED visits and unplanned admissions, while ChCI led for 30-day admissions (AUROC 0.613) and readmissions (AUROC 0.734). Combining multimorbidity with healthcare utilization features yielded the highest discrimination (AUROC 0.596–0.777), with readmissions most predictable. Multimorbidity ranked among the top predictors across outcomes.</p> Conclusions <p>Multi-source phenotyping enhances chronic condition detection and prediction. Weighted indices offer modest benefits over disease counts, with optimal choice depending on the prediction task. Multimorbidity adds consistent value alongside utilization measures, supporting its routine use in risk stratification to improve population health management.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Multimorbidity measurement strategies for predicting hospital visits

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月12日

查看全文
  • Bernardo Neves,
  • José M. Moreira,
  • Simão Gonçalves,
  • Jorge Cerejo,
  • Inês Mota,
  • Nuno A. Silva,
  • Francisca Leite,
  • Mário J. Silva

摘要

Introduction

Multimorbidity is a major challenge for healthcare systems. While multiple methods exist to measure it from electronic health records (EHRs), their relative performance for predicting hospital utilization is unclear.

Study Design and Methods

We conducted a retrospective cohort study using 15 years of EHR data (2007–2022) from a Portuguese hospital, including 925,508 patients and 9·7 M visits. Three phenotyping strategies were compared: a multi-source rule-based dictionary, Clinical Classification Software Refined (CCSR) mapping, and drug-based mapping. Five multimorbidity indices were evaluated: Charlson Comorbidity Index (ChCI), Elixhauser, Multimorbidity Weighted Index (MWI), RxRisk, and disease counts. Outcomes included emergency department (ED) visits, hospital admissions, unplanned admissions, and readmissions over 30–365 days, modeled with logistic regression (LR) and XGBoost.

Results

Best performance was achieved with XGBoost (AUROC 0.671–0.681 for ED visits, 0.663–0.668 for admissions, 0.773–0.781 for unplanned admissions, 0.798–0.848 for readmissions), with AUPRC patterns consistent with AUROC rankings. In LR models comparing indices, multimorbidity improved AUROC by 0.024–0.150 over demographics. MWI performed best for ED visits and unplanned admissions, while ChCI led for 30-day admissions (AUROC 0.613) and readmissions (AUROC 0.734). Combining multimorbidity with healthcare utilization features yielded the highest discrimination (AUROC 0.596–0.777), with readmissions most predictable. Multimorbidity ranked among the top predictors across outcomes.

Conclusions

Multi-source phenotyping enhances chronic condition detection and prediction. Weighted indices offer modest benefits over disease counts, with optimal choice depending on the prediction task. Multimorbidity adds consistent value alongside utilization measures, supporting its routine use in risk stratification to improve population health management.